You do know it wasn't consider price sensitive because RAP already announced to the market they were doing clinical trial to screen for COVID-19.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp expands COVID-19 clinical program
Ann: ResApp expands COVID-19 clinical program, page-22
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online